David Dalton, MD
Urology · Indianapolis, INNPI 1932606357
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,575 of the $3,188 with a category attached, or 80.8%. 9 manufacturers reported payments, led by Boston Scientific at 47.5% of the total. Reporting peaked in 2023 at $1,656 and has fallen 62.7% since, to $618 in 2025. That places this record below the midpoint for urology clinicians in IN, where the typical reported total is $3,350.
Across 35 payments — averaging $91.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Coloplast$928
- Calyxo, Inc.$289
- Richard Wolf Medical Instruments Corp.$120
- Cook Medical LLC$101
- Laborie Medical Technologies Corp.$87
- plus $148 from 3 others
What the payments were for
- Travel & lodging$61319%
- Food & beverage$2,57581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 18 | $1,514 |
| Coloplast | 7 | $928 |
| Calyxo, Inc. | 2 | $289 |
| Richard Wolf Medical Instruments Corp. | 2 | $120 |
| Cook Medical LLC | 2 | $101 |
| Laborie Medical Technologies Corp. | 1 | $87 |
| Urogen Pharma, Inc. | 1 | $64 |
| Tolmar, Inc. | 1 | $45 |
| Olympus America Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$780
- GENERAL ERECTILE DYSFUNCTION$364
- CVAC Aspiration System$289
- SUPRIS$110
How this compares
$3,188 in reported general payments places this provider in the 45th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 11 | $6,486 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $276 |
| Dutasteride | 12 | $148 |
| Tamsulosin Hcl | 17 | $85 |
| Ciprofloxacin Hcl | 14 | $62 |
| Oxybutynin Chloride | 11 | $53 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other urology in Indianapolis
- Michael BorofskyIndianapolis$244K
- Marcelino RiveraIndianapolis$171K
- Helen BernieIndianapolis$100K
- Austen SladeIndianapolis$73K
- Jacob RustIndianapolis$57K
- Alvin WeeIndianapolis$46K
- Jason SprungerIndianapolis$30K
- Steven KheyfetsIndianapolis$18K
- Hristos KaimakliotisIndianapolis$12K
- Adri DurantIndianapolis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.